Wird geladen...
Alteration of metabolite profiling by cold atmospheric plasma treatment in human myeloma cells
BACKGROUND: Despite new progress of chemotherapy in multiple myeloma (MM) clinical treatment, MM is still a refractory disease and new technology is needed to improve the outcomes and prolong the survival. Cold atmospheric plasma is a rapidly developed technology in recent years, which has been wide...
Gespeichert in:
| Veröffentlicht in: | Cancer Cell Int |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859683/ https://ncbi.nlm.nih.gov/pubmed/29568236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-018-0541-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|